Dennis Langer - Jun 30, 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Natalie Munk For: Dennis H. Langer
Stock symbol
MYGN
Transactions as of
Jun 30, 2022
Transactions value $
$0
Form type
4
Date filed
6/30/2022, 04:37 PM
Previous filing
Jun 3, 2022
Next filing
Mar 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MYGN Common Stock 107K Jun 30, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MYGN Non-Qualified Stock Option (right to buy) 30K Jun 30, 2022 Common Stock 30K $27.61 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Dennis Langer is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as a Company Board of Director, effective June 30, 2022, and therefore is no longer subject to Section 16 reporting.